Clinical–alimentary tractThe Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study
Section snippets
Data Sources
Data for this study were derived from the Manitoba Health administrative databases. Manitoba Health provides universal health insurance for Manitoba residents that includes coverage for physician and hospital services. Manitoba Health maintains computerized records that are based on the use of health care services by individuals in the province, including admissions to hospitals and physician visits. For each physician service the patient’s identification, the date of service, the diagnosis
Results
There were 8072 patients with IBD who met our administrative definitions from April 1, 1984 to March 31, 2003. This included 4193 patients with Crohn’s disease and 42,405 person-years of observation with disease and 31,365 person-years of observation without disease. There were 3879 patients with UC and 37,335 person-years of observation with disease and 31,904 person-years of observation without disease. There were 6 patients each with Crohn’s disease and UC in whom age-matched, sex-matched,
Discussion
A number of case reports and case series have suggested that the chronic inflammatory diseases we studied are increased in patients with IBD. A recent case-control study was performed at the Mayo Clinic.11 In that study, 243 patients with IBD presenting to the specialty clinic at Mayo Clinic were enrolled over an 8-month period. Controls were identified from outpatients seen at the Mayo Clinic who did not have IBD and were matched to IBD patients by age, sex, and geographic residence. This
References (69)
- et al.
The prevalence of extraintestinal diseases in inflammatory bowel diseasea population-based study
Am J Gastroenterol
(2001) - et al.
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission
Am J Gastroenterol
(2002) - et al.
Pulmonary abnormalities in respiratory asymptomatic patients with inflammatory bowel disease
Eur J Int Med
(2002) - et al.
The use of induced sputum in the assessment of pulmonary involvement in Crohn’s disease
Am J Gastroenterol
(2000) - et al.
Association of ulcerative colitis with multiple sclerosis (letter)
Lancet
(1982) - et al.
Concurrence of inflammatory bowel disease and multiple sclerosis
Mayo Clin Proc
(2000) - et al.
Acute sensorineural hearing loss associated with Crohn’s disease
Am J Gastroenterol
(1998) - et al.
Peripheral neuropathy in Crohn’s disease patients treated with metronidazole
Gastroenterology
(1985) - et al.
Glomerulonephritis associated with inflammatory bowel disease
Gastroenterology
(1990) - et al.
Renal and urologic complications of inflammatory bowel disease
Am J Gastroenterol
(1998)
IgA antiglomerular basement membrane nephritis associated with Crohn’s diseasea case report and review of glomerulonephritis in inflammatory bowel disease
Am J Kidney Dis
5-aminosalicylic acids and the risk of renal diseasea large British epidemiologic study
Gastroenterology
Simultaneous occurrence of inflammatory bowel disease and thyroid disease
Am J Gastroenterol
Clinical patterns in Crohn’s diseasea statistical study of 615 cases
Gastroenterology
Autoimmune disease
N Engl J Med
Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases
Arthritis Rheum
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
Proc Natl Acad Sci U S A
Registries and administrative dataorganization and accuracy
Med Care
The epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian provincea population-based study
Am J Epidemiol
Application of a validated method using medical claims data to demonstrate very high prevalence and incidence of multiple sclerosis in a Canadian province
Am J Epidemiol
The incidence of fractures among patients with IBDa population-based study
Ann Intern Med
The incidence of venous thromboembolic disease among patients with IBDa population-based study
Thromb Haemost
The incidence of cancer among patients with IBDa population-based study
Cancer
Autoimmune disorders and extraintestinal manifestations in first degree familial and sporadic inflammatory bowel diseasea case-control study
Inflamm Bowel Dis
The musculoskeletal complications of Crohn’s disease
Medicine
Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients
Scand J Gastroenterol
Peripheral arthropathies in inflammatory bowel diseasetheir articular distribution and natural history
Gut
Pulmonary complications in patients with inflammatory bowel disease
Hepatogastroenterology
Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease
Thorax
Pulmonary function abnormalities in patients with ulcerative colitis
Am J Gastroenterol
Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease
J Clin Gastroenterol
Clinical and radiological characteristics of lung disease in inflammatory bowel disease
Eur Respir J
Pulmonary manifestations of inflammatory bowel disease
Inflamm Bowel Dis
The lung in inflammatory bowel disease
Medicine (Baltimore)
Cited by (477)
Inflammatory Bowel Disease With Chronic Kidney Disease and Acute Kidney Injury
2023, American Journal of Preventive MedicineHost immune responses in COVID-19: implication for preexisting chronic systemic inflammation
2023, Genomic Surveillance and Pandemic Preparedness5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
2024, Nature CommunicationsUnraveling the connection: Uveitis prevalence and risk factors in psoriasis patients — a population-based study
2024, Journal of DermatologyIncreased risk of obstructive lung disease in inflammatory bowel disease: A population-based cohort study
2024, United European Gastroenterology JournalThe Genetics of Inflammatory Bowel Disease
2024, Molecular Diagnosis and Therapy
Supported in part by a Canadian Institutes of Health Research Investigator Award and by a Crohn’s and Colitis Foundation of Canada Research Scientist Award (to C.N.B.).